Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06615739 · ClinicalTrials.gov registry record
Comprehensive SRS Regenerex Tissue Attachment
A clinical trial of Arthroplasty Complications and Osteo Arthritis Shoulders, sponsored by Zimmer Biomet.
- Active
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT06615739: Active study of Arthroplasty Complications and Osteo Arthritis Shoulders, sponsored by Zimmer Biomet.
NCT06615739 is a study of Arthroplasty Complications and Osteo Arthritis Shoulders that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 22 participants, below the 588-participant average among 5 other Arthroplasty Complications trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06615739, a study of Arthroplasty Complications and Osteo Arthritis Shoulders, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.
Primary Outcome
This will be established by recording the incidence and frequency of device revisions. Kaplan-Meier survival analysis is a statistical method that estimates survival rates over time and accounts for factors that can affect implant survival.
Conditions Studied
Interventions
- DEVICE Regenerex Tissue Attachment Augments
Study Locations (1)
Florida
- Toman Orthopedics and Sports Med - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT06615739 still lists
NCT06615739 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 588-participant average among 5 other Arthroplasty Complications trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Arthroplasty Complications appearing as the primary indexed condition, and to 1 intervention - of which Regenerex Tissue Attachment Augments is the first listed.
NCT06615739 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06615739 about?
NCT06615739 is a clinical study titled "Comprehensive SRS Regenerex Tissue Attachment". The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.
What is the current status of trial NCT06615739?
This trial is currently active not recruiting. The enrollment target is 22 participants. The study started on 2024-10-22. Estimated completion is 2026-12-31.
What conditions does trial NCT06615739 study?
This clinical trial studies the following conditions: Arthroplasty Complications, Osteo Arthritis Shoulders.
What interventions are being tested in trial NCT06615739?
The interventions under investigation include: Regenerex Tissue Attachment Augments (DEVICE).
Who is sponsoring clinical trial NCT06615739?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06615739 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
RECRUITING · NA
-
Persona Revision Knee System Outcomes
RECRUITING
-
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
RECRUITING · NA
-
Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement
RECRUITING · NA
-
Long-term Outcomes of Complex Conversion Total Hip Arthroplasty
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI